Global Bioinformatics Market Size, Share, Trends and Growth Analysis Report – Segmented By Sector, Products & Services (Bioinformatics Platforms, Knowledge Management Tools and Bioinformatics Services), Application and Region - Industry Analysis From 2025 to 2033
As per our research analysis report, the global bioinformatics market size was valued at USD 18.83 billion in 2024. The global bioinformatics market is forecasted to be worth USD 92.10 billion by 2033 and USD 22.46 billion by 2025, growing at a CAGR of 19.29% during the forecast period.

Bioinformatics combines computer sciences, molecular biology, biotechnology, and statistics. It is a field of collecting, classifying, storing, and analyzing biological and biochemical information by using computer-based software tools. Genomics and proteomics are activities in that bioinformatics are used on a large scale. The field recently includes artificial intelligence and computer sciences for the development in the microbiology and genetic codes section. Additionally, several companies have expanded their innovation in gene expression, gene sequencing, and new drug discovery studies.
Growing support and initiatives from the various governments and the implementation of new technologies are majorly propelling the growth of the global bioinformatics market.
The global bioinformatics market is expected to grow significantly due to rising government initiatives and funding for genomics-based R&D, increasing technology use in drug discovery and biomarker development. In addition, the gradual reduction of DNA sequencing costs is an essential driver of the industry's expected progress and is the primary driver in the global bioinformatics market.
The rise in demand for integrated data and the cost of sequencing create growth opportunities for the market. Besides, the need for nucleic acid and protein sequencing will continue to increase, and increasing proteomics & genomics applications are positively impacting the market's growth. As a result, the global bioinformatics market is expected to grow significantly shortly. Government and private sector investments in the development of innovative products are expected to drive market growth during the forecast period.
The data storage and analysis application that can store large amounts of genomic and proteomic information and facilitate research activities from aging & carcinogenesis to the prevention and treatment of genetic diseases is anticipated to present growth opportunities for the market. Therefore, significant contributions to the development of the industry during the forecast period are also expected in the global bioinformatics market.
The lack of skilled staff, standard data formats, easy-to-use tools available at bargain prices, and the inability to use the platform to integrate large datasets generated by bioinformatics is expected to hinder the bioinformatics market growth.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| Segments Covered | By Sector, Products & Services, Application, and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis; Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
| Market Leaders Profiled | Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millennium Inc., Illumina Inc., Thermo Fisher Scientific Inc. |
Based on the sector, the medical biotechnology segment is expected to account for the leading share in the global market during the forecast period due to the growing need to develop new drugs at low prices and the use of bioinformatics in pharmaceutical companies to develop drugs. In addition, bioinformatics has two most traditional applications in the target drug discovery and validation process. Furthermore, the academic sector is also anticipated to grow at a healthy rate in the market during the forecast period due to the development institute's research and projects.

Based on products & services, the knowledge management tools segment is estimated to register the largest share in the global, on the other hand, market. Bioinformatics platforms are the fastest-growing sub-segment based on products & services.
The data analytics is estimated to showcase a robust CAGR from 2025 to 2033 due to the demand for high-performing sequencing data solutions. Furthermore, genetic sequencing is expected to have the fastest growth in the coming years due to rising awareness about genome and exome technologies because of the low cost.
Based on the applications segment, Genomics accounts for the largest market share during the forecast period. The genomics application segment is grabbing growth in this market due to the increasing Application in gene sequencing. The proteomics segment is expected to grow in the coming years due to new technologies and several research projects in the bioinformatics market.

Regionally, the North American regional market is predicted to lead the global bioinformatics market, followed by Europe. However, Asia-Pacific is the fastest-growing market in the world. Factors like rising funding for research, growing demand for bioinformatics in proteomics and genomics research, and technological advancements are expected to drive the rise of this market.
The Bioinformatics market in the Asia Pacific will grow fastest, with double-digit expected growth from 2025 to 2033, thanks to the improved healthcare infrastructure and development plans adopted by regional pharmaceutical companies. It is expected to be accomplished. Many infectious disease patients are in the Asia-Pacific region, accelerating the market's demand. APAC accounts for 60% of the world's total population, so a low prevalence means many infected people. Emerging economies, such as India and Australia, also contribute to revenue sharing and progress elsewhere in the Asia-Pacific region. As service outsourcing gains momentum, an increasing number of Asian countries are participating in establishing infrastructure and are expected to influence sector revenue generation through government investment and academic innovation.
The Chinese bioinformatics market is expected to account for the largest share in this regional market during the forecast period due to modern healthcare infrastructure, growing penetration of cutting-edge research, and clinical laboratory techniques driving the bioinformatics market of this APAC region.
The Japanese market is another lucrative region in the Asia Pacific, filled with technological advancements and the growing decoding of genetic sequences. However, a shortage of skilled bioinformatics professionals, high cost, and interaction hamper the growth.
The European market has experienced stable growth in the recent past and is predicted to be the same throughout the forecast period. As a result, this regional market is forecasted to showcase a CAGR of 26.8% from 2025 to 2033. Germany is the fastest-growing market among European nations of Europe and is predicted to grow at a CAGR of 33.12% during the forecast period.
The Latin American region is projected to grow at a healthy CAGR of 16.2% between 2025 to 2033. This regional market was dominated by Brazil in 2023, with over 35%, followed by Mexico.
Some of the companies that are playing a dominating role in the global bioinformatics market include
This research report on the global bioinformatics market has been segmented and sub-segmented based on the sector, products & services, application, and region.
By Sector
By Products and Services
By Application
By Region
Frequently Asked Questions
Bioinformatics is the interdisciplinary field that uses software tools, algorithms, and databases to analyze biological data. It plays a key role in genomics, proteomics, drug discovery, and personalized medicine.
The surge in genomic research, advancements in sequencing technologies, and increasing demand for personalized medicine are major drivers. Pharmaceutical and biotech companies rely heavily on bioinformatics tools for R&D efficiency.
Bioinformatics is widely used in pharmaceuticals, biotechnology, healthcare, agriculture, and environmental research. It supports everything from gene sequencing to protein structure analysis.
Data complexity, integration issues, and high costs of advanced computational systems are major challenges. Limited skilled professionals also slow adoption in some regions.
North America dominates due to advanced research infrastructure and high investment in genomics. Europe and Asia-Pacific are rapidly emerging with strong government support.
Applications include genomics, proteomics, metabolomics, drug design, molecular modeling, and precision medicine. These tools help decode biological information for scientific breakthroughs.
Key players include Agilent Technologies, Affymetrix Inc., ABM, Illumina Inc., Thermo Fisher Scientific Inc.,
The market is growing consistently, driven by genomic research and digitalization in biotechnology. It is expected to expand robustly over the coming decade.
Artificial intelligence, machine learning, cloud analytics, and high-performance computing (HPC) are widely used. These technologies improve accuracy, speed, and predictive capabilities.
Trends include AI-driven analysis, cloud-native bioinformatics, growing focus on multi-omics integration, and automated workflows. These advancements will reshape research and precision healthcare.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region